INTLOOP Inc. Logo

INTLOOP Inc.

Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.

9556 | T

Overview

Corporate Details

ISIN(s):
JP3153180009
LEI:
Country:
Japan
Address:
港区赤坂二丁目4番6号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

INTLOOP Inc. is a business creation-type consulting firm that provides comprehensive solutions for corporate transformation and management challenges. The company's operations are centered on a synergistic model that integrates consulting with several key business lines. Core offerings include PMO Solutions, providing project and resource management supported by a network of approximately 6,000 PMO specialists, and end-to-end Technology Solutions that span from strategic planning to system development. A primary differentiator is its Professional HR Solutions division, which operates one of Japan's largest talent platforms, connecting clients with over 49,000 registered freelance professionals. The company also offers recruitment support for consultants and engineers and manages various web-based matching platforms. This integrated approach allows INTLOOP to deliver tailored human capital and technology resources to drive project success for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 07:55
Registration Form
確認書
Japanese 8.8 KB
2025-10-27 07:51
Registration Form
有価証券報告書-第21期(2024/08/01-2025/07/31)
Japanese 2.1 MB
2025-07-04 10:03
M&A Activity
臨時報告書
Japanese 29.4 KB
2025-03-14 03:40
Interim Report
確認書
Japanese 8.7 KB
2025-03-14 03:37
Interim Report
半期報告書-第21期(2024/08/01-2025/07/31)
Japanese 201.0 KB
2025-02-10 07:48
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-10-31 07:12
Governance Information
内部統制報告書-第20期(2023/08/01-2024/07/31)
Japanese 23.0 KB
2024-10-31 07:09
Registration Form
確認書
Japanese 8.6 KB
2024-10-31 07:05
Registration Form
有価証券報告書-第20期(2023/08/01-2024/07/31)
Japanese 1.8 MB
2024-10-29 08:41
Post-Annual General Meeting Information
臨時報告書
Japanese 23.0 KB
2024-10-07 10:06
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-06-14 08:08
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-06-14 08:06
Quarterly Report
四半期報告書-第20期第3四半期(2024/02/01-2024/04/30)
Japanese 166.1 KB
2024-03-14 07:09
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-03-14 07:07
Quarterly Report
四半期報告書-第20期第2四半期(2023/11/01-2024/01/31)
Japanese 203.4 KB

Automate Your Workflow. Get a real-time feed of all INTLOOP Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INTLOOP Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INTLOOP Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.